Abiopharma

LionGold Corp Ltd (“LionGold or “the Company”) is a Main Board SGX listed
investment holding company focused on gold mining, mine development and
exploration. Primary gold interests are currently in Ghana and Australia. The
Company aims to become a global, mid-tier gold company by 2014 through a
combination of acquisitions and organic growth. Acquisition prospects will have
scalable resources with scope for rapid enhancement. Targets include junior
mining companies and privately held projects in an advanced stage of
development or a nascent stage of production across a range of geographies. The
intention behind this selective approach is to unlock asset value while
building out the gold business. The Group continues to have investments in
legacy, non-core segments such as renewable energy and the manufacturing of
office equipment.

Additional info from SGX:

LionGold Corp Ltd (“LionGold or “the Company”) is a Main Board SGX listed
investment holding company focused on gold mining, mine development and
exploration. Primary gold interests are currently in Ghana and Australia. The
Company aims to become a global, mid-tier gold company by 2014 through a
combination of acquisitions and organic growth. Acquisition prospects will have
scalable resources with scope for rapid enhancement. Targets include junior
mining companies and privately held projects in an advanced stage of
development or a nascent stage of production across a range of geographies. The
intention behind this selective approach is to unlock asset value while
building out the gold business. The Group continues to have investments in
legacy, non-core segments such as renewable energy and the manufacturing of
office equipment.